Alpha up-beta down adrenergic regulation: a possible mechanism of action of antidepressant treatments. 1984

J Vetulani, and L Antkiewicz-Michaluk, and A Rokosz-Pelc, and A Pilc

The presently reported findings: that spaced electroconvulsive treatment increases the density of alpha-1 adrenoceptor in the spinal cord as well as in the cerebral cortex of the rat, that treatment with various classes of antidepressant drugs, including antidepressant neuroleptics, affects in a similar manner alpha-adrenoceptors, elevating within 2 weeks the density of alpha-1, and depressing the density of alpha-2 subpopulation, and that prolonged imipramine treatment in investigated strains of rats does not depress the beta adrenoceptor density within 3 weeks, but only after 6-week-treatment such an effect is observed, are discussed together with our earlier results. It is suggested that the first effect of an antidepressant therapy may be a transient upregulation of alpha-2 adrenoceptors causing a decrease in noradrenaline utilization, but this is followed rapidly by an upregulation of alpha-1 adrenoceptors and depression of density of alpha-2 adrenoceptors. Eventually, adaptive beta adrenoceptor down-regulation follows. The final effect of an antidepressant therapy is a specific facilitation of neurotransmission regulated by alpha-1 adrenoceptors.

UI MeSH Term Description Entries
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008566 Membranes Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures. Membrane Tissue,Membrane,Membrane Tissues,Tissue, Membrane,Tissues, Membrane
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011942 Receptors, Adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation. Adrenergic alpha-Receptor,Adrenergic alpha-Receptors,Receptors, alpha-Adrenergic,alpha-Adrenergic Receptor,alpha-Adrenergic Receptors,Receptor, Adrenergic, alpha,Adrenergic alpha Receptor,Adrenergic alpha Receptors,Receptor, alpha-Adrenergic,Receptors, alpha Adrenergic,alpha Adrenergic Receptor,alpha Adrenergic Receptors,alpha-Receptor, Adrenergic,alpha-Receptors, Adrenergic
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155

Related Publications

J Vetulani, and L Antkiewicz-Michaluk, and A Rokosz-Pelc, and A Pilc
August 1985, The Journal of allergy and clinical immunology,
J Vetulani, and L Antkiewicz-Michaluk, and A Rokosz-Pelc, and A Pilc
September 1997, The Journal of pharmacology and experimental therapeutics,
J Vetulani, and L Antkiewicz-Michaluk, and A Rokosz-Pelc, and A Pilc
February 1988, Postgraduate medicine,
J Vetulani, and L Antkiewicz-Michaluk, and A Rokosz-Pelc, and A Pilc
July 1990, The Journal of pharmacology and experimental therapeutics,
J Vetulani, and L Antkiewicz-Michaluk, and A Rokosz-Pelc, and A Pilc
September 1985, Life sciences,
J Vetulani, and L Antkiewicz-Michaluk, and A Rokosz-Pelc, and A Pilc
January 1958, Journal of clinical and experimental psychopathology,
J Vetulani, and L Antkiewicz-Michaluk, and A Rokosz-Pelc, and A Pilc
January 1985, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
J Vetulani, and L Antkiewicz-Michaluk, and A Rokosz-Pelc, and A Pilc
April 1987, Biochemical pharmacology,
J Vetulani, and L Antkiewicz-Michaluk, and A Rokosz-Pelc, and A Pilc
June 1981, European journal of pharmacology,
Copied contents to your clipboard!